Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

CYTOVIA Therapeutics and MACROMOLTEK to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2 (COVID-19)

Wednesday, April 08, 2020

Cytovia Therapeutics an emerging biopharmaceutical company developing Natural Killer NK immunotherapies for cancer and infectious diseases announced today that it is expanding its programs to help urgently address the current SAR CoV COVID crisis

GSK and Vir Biotechnology enter collaboration to find coronavirus solutions

Tuesday, April 07, 2020

GlaxoSmithKline plc and Vir Biotechnology Inc announced they have signed a binding agreement to enter into a collaboration to research and develop solutions for coronaviruses including SARSCoV the virus that causes COVID

Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery

Tuesday, April 07, 2020

Gilead Sciences Inc and Second Genome a leader in microbiome science today announced that the companies have entered into a fouryear strategic collaboration to identify biomarkers associated with clinical response in up to five of Gileads pipeline co...

Chirin Group, in collaboration with Covar Pharmaceuticals

Monday, April 06, 2020

The discovery of biopharmaceutical companies focusing on developing new therapeutics to address unmet needs in areas such as infectious rare and metabolic diseases The Population Nasdaq APM Aptram Group announced that it has launched a new R D proj...

Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy

Monday, April 06, 2020

Biotest BPL LFB and Octapharma have joined an alliance formed by CSL Behring and Takeda Pharmaceutical Company Limited to develop a potential plasmaderived therapy for treating COVID The alliance will begin immediately with the investigational deve...

ICON Signs New Service Agreement With Pfizer

Saturday, April 04, 2020

ICON plc a leading global provider of drug and device development and commercialisation services to the pharmaceutical biotechnology and medical device industries today announced it has signed a threeyear agreement with Pfizer Inc Under the terms of...

Seneca Biopharma, Inc. Announces the Completion of Stem Cell Manufacturing Facility in China

Saturday, April 04, 2020

Seneca Biopharma Inc a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need today announced the completion of its new cell manufacturing facility in Suzhou China The facility will be used to manufac...

Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies

Friday, April 03, 2020

Fate Therapeutics Inc a clinicalstage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders announced today a global collaboration and option agreement with Janssen Biotech Inc J...

Kite Licenses Antibodies and Establishes Collaboration With Teneobio in Multiple Myeloma

Friday, April 03, 2020

Kite a Gilead Company and Teneobio Inc announced the companies have entered into a license and collaboration agreement through which Kite will receive exclusive rights to certain antibodies directed to Bcell maturation antigen BCMA

Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19

Thursday, April 02, 2020

Citius Pharmaceuticals Inc a specialty pharmaceutical company focused on developing and commercializing critical care drug products today signed an exclusive sixmonth option agreement to inlicense a stemcell therapy for acute respiratory distress syn...